Shanghai, China

Yinhua He

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Shanghai Raising Pharmaceutical Co., Ltd., Shanghai Ri Xin Biotechnology Co., Ltd.. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yinhua He. Retrieved from https://idiyas.com/inventor/yinhua-he

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Yinhua He's passion for innovation and his relentless pursuit of excellence:

Title: Yinhua He: Pioneering Innovation in Shanghai

Introduction:

Yinhua He, a visionary inventor based in Shanghai, China, is a trailblazer in the field of pharmaceutical polymorphs. With a keen eye for detail and a passion for pushing the boundaries of scientific discovery, he continues to inspire the next generation of inventors and researchers in Shanghai and beyond.

Latest Patents:

Yinhua He's latest patents include the groundbreaking work on crystalline polymorphs of benfotiamine. These five distinct crystalline forms, designated as A, B, C, D, and E, have revolutionized the treatment of Vitamin B1 deficiency, metabolic disorders, mental illnesses, diabetes complications, and neurodegenerative diseases. His innovative processes for preparation and transformation have led to the development of pure crystalline forms and new solvates, particularly hydrates.

Career Highlights:

Throughout his illustrious career, Yinhua He has made significant contributions to the pharmaceutical industry. He has worked with esteemed companies such as Shanghai Ri Xin Biotechnology Co., Ltd. and Shanghai Raising Pharmaceutical Co., Ltd., where his expertise has been instrumental in driving forward cutting-edge research and development initiatives.

Collaborations:

Yinhua He has collaborated with esteemed colleagues such as Chunjiu Zhong and Xuefeng Mei, forging strong partnerships that have paved the way for groundbreaking discoveries in the field of pharmaceutical polymorphs. Together, they have synergized their skills and knowledge to create innovative solutions that have the potential to revolutionize modern medicine.

Conclusion:

In conclusion, Yinhua He's dedication to innovation and his unwavering pursuit of excellence serve as a testament to his pioneering spirit. His achievements in the realm of crystalline polymorphs underscore his commitment to pushing the boundaries of scientific knowledge and his passion for making a positive impact on the world. Yinhua He's legacy will continue to inspire generations of inventors and researchers to strive for greatness in their pursuit of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…